Clinical Trials Directory

Trials / Completed

CompletedNCT02938650

Nitrosomonas Eutropha on Nitrolipids in the Skin

Assessing the Role of Nitrosomonas Eutropha on Nitrolipids in the Skin

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

We are looking to see how the addition of nitrosomonas alters the presence of nitrolipids and inflammatory cytokines on the skin.

Detailed description

We are looking to see how the nitrosomonas alters nitrolipids in the skin and the inflammatory cytokines of the skin. We will be using healthy subjects over the course of 2 weeks. Subjects will be using a neutral cleanser for one week prior to the study, skin microbiome,facial photography, lipid and cytokine measurements will be taken at baseline. Subjects will then start using nitrosomonas spray twice daily for one week. There is a portion of the study where the subjects will have skin microbiome, facial photography, lipid measurements, blood pressure measurements and a bloow draw before and after using the nitrosomonas spray for one week.

Conditions

Interventions

TypeNameDescription
DRUGNitrosomonas eutrophaSubjects will get nitrosomonas eutropha to apply for one week. There is only one arm to this study. Subjects will apply the medication twice a day for one week.

Timeline

Start date
2016-10-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2016-10-19
Last updated
2017-10-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02938650. Inclusion in this directory is not an endorsement.